AFRM vs INM · P/E 590, rev $3.22B vs rev $4.9M
Affirm Holdings Inc (AFRM) versus InMed Pharmaceuticals Inc (INM) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. Revenue was up 7.5% from 2024-06-30 to 2025-06-30. INM currently screens at market cap $5.2M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. INM currently screens at market cap $5.2M.
Not investment advice. Open the AFRM and INM stock pages for the full models.
Not investment advice.